Bailard Inc. Sells 1,345 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Bailard Inc. lowered its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 9.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 13,337 shares of the real estate investment trust’s stock after selling 1,345 shares during the period. Bailard Inc.’s holdings in Sabra Health Care REIT were worth $231,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Quarry LP bought a new position in Sabra Health Care REIT during the third quarter valued at approximately $30,000. Assetmark Inc. lifted its holdings in shares of Sabra Health Care REIT by 168.4% during the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock valued at $37,000 after buying an additional 1,231 shares during the period. Wilmington Savings Fund Society FSB purchased a new position in shares of Sabra Health Care REIT in the 3rd quarter worth $59,000. Harbor Capital Advisors Inc. purchased a new stake in Sabra Health Care REIT during the third quarter valued at $78,000. Finally, International Assets Investment Management LLC lifted its holdings in Sabra Health Care REIT by 1,761.0% in the third quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 5,776 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Stock Up 0.4 %

Shares of SBRA stock opened at $17.09 on Thursday. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. Sabra Health Care REIT, Inc. has a one year low of $13.31 and a one year high of $20.03. The company’s fifty day moving average price is $16.77 and its 200-day moving average price is $17.64. The company has a market capitalization of $4.07 billion, a price-to-earnings ratio of 32.25, a PEG ratio of 1.97 and a beta of 1.27.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, meeting analysts’ consensus estimates of $0.36. The business had revenue of $182.35 million for the quarter, compared to analysts’ expectations of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. Sell-side analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 7.02%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 226.42%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on SBRA shares. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Mizuho reaffirmed a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a report on Thursday, December 5th. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research note on Tuesday, January 7th. Finally, Truist Financial lowered Sabra Health Care REIT from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $19.17.

Sabra Health Care REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.